Oncternal Therapeutics
(NASDAQ) ONCT
Oncternal Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$1.67M
Net Income (TTM)
$34.58M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ONCT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Oncternal Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
27
CEO
James B. Breitmeyer, MD, PhD
Website
www.oncternal.comHeadquarters
San Diego, CA 92130, US
ONCT Financials
Key Financial Metrics (TTM)
Gross Margin
-37%
Operating Margin
-53%
Net Income Margin
-50%
Return on Equity
62%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$28.97M
Operating Income
$41.71M
EBITDA
$2.23M
Operating Cash Flow
$32.16M
Capital Expenditure
$0.00
Free Cash Flow
$32.16M
Cash & ST Invst.
$34.26M
Total Debt
$318.00K
Oncternal Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
27
N/A
Net Income
$8.46M
+14.2%
EBITDA
$8.68M
+15.8%
Quarterly Fundamentals
Net Cash
$14.39M
-64.0%
Accounts Receivable
$344.00K
N/A
Inventory
$0.00
+100.0%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$191.00K
-36.8%
Return on Assets
-1.07%
N/A
Return on Invested Capital
-1.32%
N/A
Free Cash Flow
$6.95M
-26.1%
Operating Cash Flow
$6.95M
-26.1%